Bausch Health Companies (BHC) Amortization - Intangibles (2009 - 2026)

Bausch Health Companies (BHC) reported Amortization - Intangibles of $241.0 million for Q1 2026, down 5.86% on a YoY basis from $256.0 million in Q1 2025, and up 2.12% sequentially from $236.0 million in Q4 2025.

Bausch Health Companies (BHC) Amortization - Intangibles (2009 - 2026) Analysis & Trends

Bausch Health Companies (BHC) has 18 years of Amortization - Intangibles data on file, last reported at $241.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Amortization - Intangibles fell 5.86% year-over-year to $241.0 million; the trailing twelve-month figure through Mar 2026 stood at $986.0 million (down 6.89% YoY), and the FY2025 full-year result was $1.0 billion, down 7.06% from the prior year.
  • Amortization - Intangibles grew to $241.0 million in Q1 2026, from $236.0 million in the prior quarter.
  • In the past five years, Amortization - Intangibles ranged from a high of $313.0 million in Q4 2022 to a low of $236.0 million in Q4 2025.
  • A 5-year average of $271.2 million and a median of $270.0 million in 2024 frame the typical range for Amortization - Intangibles.
  • Across the five-year window, Amortization - Intangibles decreased 16.11% in 2022 and rose 8.3% in 2024, its largest moves.
  • Tracing BHC's Amortization - Intangibles over 5 years: stood at $313.0 million in 2022, then decreased by 9.9% to $282.0 million in 2023, then decreased by 8.16% to $259.0 million in 2024, then decreased by 8.88% to $236.0 million in 2025, then increased by 2.12% to $241.0 million in 2026.
  • Business Quant data shows BHC's Amortization - Intangibles at $241.0 million in Q1 2026, $236.0 million in Q4 2025, and $253.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Bausch Health Companies 1.66 Bn 1.33 Bn 2.52 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 241.00 Mn
Dec 31, 2025 236.00 Mn
Sep 30, 2025 253.00 Mn
Jun 30, 2025 256.00 Mn
Mar 31, 2025 256.00 Mn
Dec 31, 2024 259.00 Mn
Sep 30, 2024 274.00 Mn
Jun 30, 2024 270.00 Mn
Mar 31, 2024 274.00 Mn
Dec 31, 2023 282.00 Mn
Sep 30, 2023 253.00 Mn
Jun 30, 2023 269.00 Mn
Mar 31, 2023 273.00 Mn
Dec 31, 2022 313.00 Mn
Sep 30, 2022 290.00 Mn
Jun 30, 2022 302.00 Mn
Mar 31, 2022 310.00 Mn
Dec 31, 2021 320.00 Mn
Sep 30, 2021 338.00 Mn
Jun 30, 2021 360.00 Mn